Company Overview of Inimex Pharmaceuticals Inc.
Inimex Pharmaceuticals Inc., a biopharmaceutical company, engages in the development and commercialization of innate defense regulators (IDRs) that modulate the body's innate defenses without causing inflammation. The company offers IMX942, an IDR product that improves survival, ameliorate tissue damage, and reduce bacterial infections through modulation of innate defenses. Its products are used to treat infections and conditions involving tissue injury; ventilator associated pneumonia, tracheobronchitis, bacteremia, endocarditis, and mucositis; and cancer diseases. Inimex Pharmaceuticals Inc. was founded in 2001 and is headquartered in Coquitlam, Canada.
3650 Wesbrook Mall
RPO Clarke Road
PO Box 64036
Coquitlam, BC V3J 7V6
Founded in 2001
Key Executives for Inimex Pharmaceuticals Inc.
Similar Private Companies By Industry
|Plexagen Diagnostics Ltd.||Americas|
|Capital 21 Holdings Inc.||Americas|
|Alpha Cancer Technologies Inc.||Americas|
|Northern Biologics Inc.||Americas|
|LifeLike BioTissue Inc.||Americas|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Inimex Pharmaceuticals Inc., please visit www.inimexpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.